Viking Therapeutics, Inc.
Clinical trials sponsored by Viking Therapeutics, Inc., explained in plain language.
-
New drug aims to speed recovery after broken hip
Disease control CompletedThis study tested whether a drug called VK5211 could help people aged 65 and older regain muscle mass after a hip fracture. It involved 108 participants who took the drug or a placebo for 12 weeks, starting 3-7 weeks after their fracture surgery. The main goal was to see if the d…
Phase: PHASE2 • Sponsor: Viking Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New weight loss pill shows promise in Mid-Stage trial
Disease control CompletedThis study tested a new daily pill called VK2735 to see if it helps people lose weight. It involved 280 adults who were obese or overweight with at least one related health issue, like high blood pressure. Participants took either the pill or a placebo (a dummy pill) for 13 weeks…
Phase: PHASE2 • Sponsor: Viking Therapeutics, Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC